Management of Parathyroid Disease during the COVID-19 Pandemic

摘要: The coronavirus disease, COVID-19, has caused widespread and sustained disruption to healthcare, not only in the delivery of emergency care, but knock-on consequences have resulted major delays elective including surgery. COVID-19 accelerated novel pathways for delivering clinical services, many which an increased reliance on technology. impacted care patients with both hypoparathyroidism hyperparathyroidism. role vitamin D prevention severe infection also been widely debated. Severe hypocalcemia can be precipitated by hypoparathyroidism. With this mind, compliance medical management, calcium supplementation, is crucial. Technology form text message reminders smartphone apps may a key ensuring this. Furthermore, clinicians should ensure that are educated symptoms steps needing taken these experienced. Patients primary hyperparathyroidism (PHPT) hypercalcemia, as well importance remaining adequately hydrated. In addition, reassured postponement parathyroidectomy likely negligible impact their condition; those symptomatic cinacalcet considered interim measure.